Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNY1 pseudogene 5 (RNY1P5)
- Target
- RNY1P5
- Molecular classification
- Pseudogene, Non-coding RNA (Y RNA family, pseudogene variant), Other
01
Overview
RNY1 pseudogene 5 (RNY1P5) is a processed pseudogene of the Y RNA family, mapped to chromosome 13 (chr13:74289100-74289214), and registered as NCBI Gene 100862667[7]. Unlike the functional RNY1 gene, which encodes a small noncoding RNA known to associate with Ro60/La ribonucleoproteins and is essential for DNA replication and implicated in cancer, cardiovascular, and autoimmune diseases[1][3][5], RNY1P5 itself is not known to be transcribed or translated, nor shown to play a direct biological or pathological role. Pseudogenes can regulate gene expression through ceRNA mechanisms, but there is no direct evidence that RNY1P5 fulfills such a function[2][4]. Therefore, it is not considered a therapeutic target.
- Other names
- RNA, Ro-associated Y1 pseudogene 5RNY1P5
02
Biological functions
Other (no direct evidence for functional biological activity of RNY1P5 specifically)Potential competing endogenous RNA (ceRNA) or miRNA sponge activity (inferred from literature on pseudogenes generally, not shown specifically for RNY1P5)[2][4]Possible involvement in post-transcriptional regulation (inferred from pseudogene mechanisms)[4][6]
03
Disease associations
Other (no disease association known for RNY1P5 directly; parental Y RNA genes implicated in cancer, cardiovascular disease, and autoimmune disease, but no direct evidence for this pseudogene)[5]Related Y RNA fragments, not RNY1P5, serve as biomarkers in cardiovascular disease (e.g., s-RNY1-5p for coronary heart disease)[3]
04
Biomarkers
s-RNY1-5p (Note: this is a Y RNA-derived small RNA, not the pseudogene, but related and used as a serum biomarker for predicting coronary heart disease events in men)[3]
Beyond the preview
Go deeper on RNY1 pseudogene 5 (RNY1P5).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RNY1 pseudogene 5 (RNY1P5).